Excluded trial | No. of trials | MD (95 % CI) | P value for MD | I 2, % | P value for heterogeneity |
---|---|---|---|---|---|
Smejkal 2011 | 0.06 (−3.72, 3.84) | 0.97 | 44 | 0.15 | |
Zhu 2011 | −1.76 (−4.51, 0.99) | 0.21 | 0 | 0.77 | |
Gradl 2009 | 0.52 (−2.96, 4.00) | 0.77 | 33 | 0.22 | |
Matziolis 2010 | −0.39 (−3.58, 2.80) | 0.81 | 37 | 0.19 | |
Konrad 2012 | 0.85 (−2.90, 4.60) | 0.66 | 22 | 0.28 |